This is not the most recent version of the article. View current version (16 MAR 2011)

Intervention Protocol

Almitrine-Raubasine combination for dementia

  1. Weimin Yang1,*,
  2. Ming Liu1,
  3. Zilong Hao1,
  4. Bo Wu1,
  5. Taixiang Wu2,
  6. Guan J Liu2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008068

How to Cite

Yang W, Liu M, Hao Z, Wu B, Wu T, Liu GJ. Almitrine-Raubasine combination for dementia (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008068. DOI: 10.1002/14651858.CD008068.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan Province, China

  2. 2

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, Chengdu, Sichuan, China

*Weimin Yang, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan Province, 610041, China. weiminyanghn@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article.View current version (16 Mar 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the clinical efficacy and safety of Duxil in the treatment of patients with dementia.